User menu

Prime study : a randomised phase 3 study of panitumumab with Folfox4 versus Folfox4 alone as first line treatment for metastatic colorectal cancer (mCRC)

Bibliographic reference Siena, Salvatore ; Douillard, Jean-Yves ; Tabernero, Josef ; Cassidy, James ; Burkes, Ronald ; et. al. Prime study : a randomised phase 3 study of panitumumab with Folfox4 versus Folfox4 alone as first line treatment for metastatic colorectal cancer (mCRC).European Multidisciplinary Colorectal Cancer Congress ((France)Nice, du 28/03/2010 au 30/03/2010). In: Annals of Oncology, Vol. 21, no. Suppl. 1, p. I13 (2010)
Permanent URL http://hdl.handle.net/2078.1/58579